» Articles » PMID: 26136641

Analyzing the Gene Expression Profile of Anaplastic Histology Wilms' Tumor with Real-time Polymerase Chain Reaction Arrays

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2015 Jul 3
PMID 26136641
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Wilms' tumor (WT) is one of the most common malignant neoplasms of the urinary tract in children. Anaplastic histology (unfavorable histology) accounts for about 10% of whole WTs, and it is the single most important histologic predictor of treatment response and survival in patients with WT; however, until now the molecular basis of this phenotype is not very clearly.

Methods: A real-time polymerase chain reaction (PCR) array was designed and tested. Next, the gene expression profile of pediatric anaplastic histology WT and normal adjacent tissues were analyzed. These expression data were anlyzed with Multi Experiment View (MEV) cluster software further. Datasets representing genes with altered expression profiles derived from cluster analyses were imported into the Ingenuity Pathway Analysis Tool (IPA).

Results: 88 real-time PCR primer pairs for quantitative gene expression analysis of key genes involved in pediatric anaplastic histology WT were designed and tested. The gene expression profile of pediatric anaplastic histology WT is significantly different from adjacent normal controls; we identified 15 genes that are up-regulated and 16 genes that are down-regulated in the former. To investigate biological interactions of these differently regulated genes, datasets representing genes with altered expression profiles were imported into the IPA for further analysis, which revealed three significant networks: Cancer, Hematological Disease, and Gene Expression, which included 27 focus molecules and a significance score of 43. The IPA analysis also grouped the differentially expressed genes into biological mechanisms related to Cell Death and Survival 1.15E(-12), Cellular Development 2.84E(-11), Cellular Growth and Proliferation 2.84E(-11), Gene Expression 4.43E(-10), and DNA Replication, Recombination, and Repair 1.39E(-07). The important upstream regulators of pediatric anaplastic histology WT were TP53 and TGFβ1 signaling (P = 1.15E(-14) and 3.79E(-13), respectively).

Conclusions: Our study demonstrates that the gene expression profile of pediatric anaplastic histology WT is significantly different from adjacent normal tissues with real-time PCR array. We identified some genes that are dysregulated in pediatric anaplastic histology WT for the first time, such as HDAC7, and IPA analysis showed the most important pathways for pediatric anaplastic histology WT are TP53 and TGFβ1 signaling. This work may provide new clues into the molecular mechanisms behind pediatric anaplastic histology WT.

Citing Articles

Characterization of Alternative Splicing in High-Risk Wilms' Tumors.

Trink Y, Urbach A, Dekel B, Hohenstein P, Goldberger J, Kalisky T Int J Mol Sci. 2024; 25(8).

PMID: 38674106 PMC: 11050615. DOI: 10.3390/ijms25084520.


Genetic Polymorphisms of the Signal Peptide and Promoter Region: Role in Wilms Tumor Susceptibility?.

Ishibashi C, Oliveira C, Guembarovski R, Hirata B, Vitiello G, Guembarovski A J Kidney Cancer VHL. 2021; 8(4):22-31.

PMID: 34722128 PMC: 8532353. DOI: 10.15586/jkcvhl.v8i4.182.


Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor.

Liu Y, Nelson M, Bailey C, Zhang P, Zheng P, Dome J Oncogene. 2021; 40(29):4809-4819.

PMID: 34155347 PMC: 8319145. DOI: 10.1038/s41388-021-01907-1.


Inhibition of Wilms' Tumor Proliferation and Invasion by Blocking TGF- Receptor I in the TGF-/Smad Signaling Pathway.

Shi Q, Wu H, Li Y, Shen L, Tian X, Lin T Biomed Res Int. 2020; 2020:8039840.

PMID: 33282954 PMC: 7685794. DOI: 10.1155/2020/8039840.

References
1.
Corbin M, De Reynies A, Rickman D, Berrebi D, Boccon-Gibod L, Cohen-Gogo S . WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?. Genes Chromosomes Cancer. 2009; 48(9):816-27. DOI: 10.1002/gcc.20686. View

2.
Dome J, Cotton C, Perlman E, Breslow N, Kalapurakal J, Ritchey M . Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006; 24(15):2352-8. DOI: 10.1200/JCO.2005.04.7852. View

3.
Tao Y, Pang L, Du X, Sun L, Hu S, Lu J . Differential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia. Int J Mol Sci. 2013; 14(2):3376-94. PMC: 3588049. DOI: 10.3390/ijms14023376. View

4.
Zumkeller W, Schwander J, Mitchell C, Morrell D, Schofield P, Preece M . Insulin-like growth factor (IGF)-I, -II and IGF binding protein-2 (IGFBP-2) in the plasma of children with Wilms' tumour. Eur J Cancer. 1993; 29A(14):1973-7. DOI: 10.1016/0959-8049(93)90455-o. View

5.
Li W, Kessler P, Yeger H, Alami J, Reeve A, Heathcott R . A gene expression signature for relapse of primary wilms tumors. Cancer Res. 2005; 65(7):2592-601. DOI: 10.1158/0008-5472.CAN-04-1532. View